Publications

Total publications All
https://www.ncbi.nlm.nih.gov/pubmed/?term=dhiman+rk 354
Citations 8970
h-index 47
i10-index 168

FOR ALL INDEXED PUBLICATION: PLEASE LOG ON TO

https://www.ncbi.nlm.nih.gov/pubmed/?term=dhiman+rk

FOR CITATIONS OF ARTICLES PUBLISHED IN INDEXED JOURNALS

https://scholar.google.co.in/citations?user=uo7xk04AAAAJ&hl=en

Article Year of Publication Citations
Lactulose improves cognitive functions and health‐related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. S Prasad, RK Dhiman, A Duseja, YK Chawla, A Sharma, R Agarwal. Hepatology 45 (3), 549-559 2007 517
Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. A Das, RK Dhiman, VA Saraswat, M Verma, SR Naik Journal of Gastroenterology and Hepatology 16 (5), 531-535 2001 296
Herbal medicines for liver diseases. RK Dhiman, YK Chawla. Digestive diseases and sciences 50 (10), 1807-1812 2005 255
Noncirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. RK Dhiman, Y Chawla, RK Vasishta, N Kakkar, JB Dilawari, MS Trehan, ...Journal of gastroenterology and hepatology 17 (1), 6-16 2002 195
The modern management of portal vein thrombosis. Y Chawla, A Duseja, RK Dhiman Alimentary pharmacology & therapeutics 30 (9), 881-894 2009 163
Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy A Gupta, RK Dhiman, S Kumari, S Rana, R Agarwal, A Duseja, Y Chawla Journal of Hepatology 53 (5), 849-855 2010 157
Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. RK Dhiman, R Kurmi, KK Thumburu, SH Venkataramarao, R Agarwal, ...Digestive diseases and sciences 55 (8), 2381-2390 2010 150
Portal hypertensive biliopathy. RK Dhiman, A Behera, YK Chawla, JB Dilawari, S Suri. Gut 56 (7), 1001-1008 2007 146
Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. D Gupta, DR Vijaya, R Gupta, RK Dhiman, M Bhargava, J Verma, ...The American journal of gastroenterology 96 (12), 3395-3399 2001 140
Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. RK Dhiman, Y Chawla, S Taneja, R Biswas, TR Sharma, JB Dilawari. Journal of clinical gastroenterology 35 (3), 222-227 2002 139
Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic? RK Dhiman, P Puri, Y Chawla, M Minz, JR Bapuraj, S Gupta, B Nagi, ... Gastrointestinal endoscopy 50 (5), 646-652 1999 139
Early indicators of prognosis in fulminant hepatic failure: An assessment of the Model for End‐Stage Liver Disease (MELD) and King's College Hospital Criteria. RK Dhiman, S Jain, U Maheshwari, A Bhalla, N Sharma, J Ahluwalia, ...Liver transplantation 13 (6), 814-821 2007 133
Probiotic VSL# 3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. RK Dhiman, B Rana, S Agrawal, A Garg, M Chopra, KK Thumburu,. Gastroenterology 147 (6), 1327-1337. e3 2014 130
Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. RK Dhiman, AK Seth, S Jain, YK Chawla, JB Dilawari. Digestive diseases and sciences 43 (6), 1311-1316 1998 129
Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. RK Dhiman, VA Saraswat, BK Sharma, SK Sarin, YK Chawla, ... Journal of gastroenterology and hepatology 25 (6), 1029-1041 2010 127
Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions.A Duseja, A Das, RK Dhiman, YK Chawla, KT Thumburu, S Bhadada, ...Annals of hepatology 6 (4), 222-226 2006 113
The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. A Duseja, A Das, R Das, RK Dhiman, Y Chawla, A Bhansali, N Kalra. Digestive diseases and sciences 52 (9), 2368-2374 2007 99
Figure connection test: a universal test for assessment of mental state. RK DHIMAN, VA SARASWAT, M VERMA, SR NAIK. Journal of gastroenterology and hepatology 10 (1), 14-23 1995 94
Minimal hepatic encephalopathy. RK Dhiman, YK Chawla. Indian Journal of Gastroenterology 28 (1), 5-16 2009 89
Radioisotope scintigraphy in the diagnosis of hepatic hydrothorax. A Bhattacharya, BR Mittal, T Biswas, RK Dhiman, B Singh, SK Jindal, ...Journal of gastroenterology and hepatology 16 (3), 317-321 2001 87
Role of paraoesophageal collaterals and perforating veins on outcome of endoscopic sclerotherapy for oesophageal varices: an endosonographic study.RK Dhiman, G Choudhuri, VA Saraswat, DK Agarwal, SR Naik 1996 87
APACHE II score is superior to SOFA, CTP and MELD in predicting the short‐term mortality in patients with acute‐on‐chronic liver failure (ACLF). A Duseja, NS Choudhary, S Gupta, RK Dhiman, Y Chawla. Journal of digestive diseases 14 (9), 484-490 2013 73
Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy. BC Sharma, DK Agarwal, RK Dhiman, SS Baijal, G Choudhuri, ...Gastroenterology 115 (1), 124-128 1998 72
Duplex Doppler sonography in patients with Budd–Chiari syndrome. Y Chawla, S Kumar, RK Dhiman, S Suri, JB Dilawari. Journal of gastroenterology and hepatology 14 (9), 904-907 1999 72
Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). A Duseja, YK Chawla, RK Dhiman, A Kumar, N Choudhary, S Taneja Digestive diseases and sciences 55 (11), 3188-3192 2010 69
Non-cirrhotic portal hypertension in pregnancy. N Aggarwal, H Sawhney, K Vasishta, RK Dhiman, Y Chawla. International journal of gynecology & obstetrics 72 (1), 1-7 2001 67
Endosonographic evaluation of the venous anatomy around the gastro-esophageal junction in patients with portal hypertension.. G Choudhuri, RK Dhiman, DK Agarwal. Hepato-gastroenterology 43 (11), 1250-1255 1995 65
Pregnancy and cirrhosis of the liver. N Aggarwal, H Sawnhey, V Suril, K Vasishta, M Jha, RK Dhiman. Australian and New Zealand journal of obstetrics and gynaecology 39 (4), 503-506 1999 61
Endosonographic, endoscopic, and histologic evaluation of alterations in the rectal venous system in patients with portal hypertension. RK Dhiman, VA Saraswat, G Choudhuri, BC Sharma, R Pandey, SR Naik. Gastrointestinal endoscopy 49 (2), 218-227 1999 61
Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. VA Saraswat, RK Dhiman, A Mishra, SR Naik. Digestive diseases and sciences 39 (1), 199-205 1994 60
CYP2C19 genetic mutations in North Indians. JK Lamba, RK Dhiman, KK Kohli. Clinical Pharmacology & Therapeutics 68 (3), 328-335 2000 56
Gut microbiota: its role in hepatic encephalopathy. R Rai, VA Saraswat, RK Dhiman - Journal of clinical and experimental Hepatology 2015 55
Prevention and management of bacterial infections in cirrhosis.Taneja SK1, Dhiman RK. Int J Hepatol. 2011;2011:784540. doi: 10.4061/2011/784540. 2011 54
Percutaneous catheter drainage of amoebic liver abscess. VA Saraswat, DK Agarwal, SS Baijal, S Roy, G Choudhuri, RK Dhiman, ...Clinical radiology 45 (3), 187-189 1992 54
Elevation of interleukin‐18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. A Sharma, A Chakraborti, A Das, RK Dhiman, Y Chawla. Immunology 128 (1pt2), e514-e522 2009 53
Hepatitis B virus co-infection in HIV infected patients.A Sud, J Singh, RK Dhiman, A Wanchu… Tropical Gastroenterology, 2001 2001 49
Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on …RK Dhiman, S Agrawal, T Gupta, A Duseja… World Journal of Gastroenterology 2014 48
Non-alcoholic fatty liver disease and metabolic syndrome—position paper of the Indian National Association for the Study of the Liver, Endocrine Society of India …A Duseja, SP Singh, VA Saraswat, SK Acharya… - Journal of clinical and Experimental Hepatology, 2015 2015 47
Ascites and spontaneous bacterial peritonitis in fulminant hepatic failure. RK Dhiman, GK Makharia, S Jain, Y Chawla. The American journal of gastroenterology 95 (1), 233-238 2000 46
Small intestinal bacterial overgrowth and toll‐like receptor signaling in patients with non‐alcoholic fatty liver disease. S Kapil, A Duseja, BK Sharma, B Singla… - Journal of Gastroenterology & Hepatology, 2016 2016 45
Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. A Duseja, KK Thumburu, A Das, RK Dhiman, YK Chawla, S Bhadada, ...Indian Journal of Gastroenterology 26 (4), 170 2007 45
Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. BK Dhillon, R Das, G Garewal, Y Chawla… - World Journal of Gastroenterology 2007 44
  • Dhiman RK, Grover GS, Premkumar M, Taneja S, Duseja A, Arora S, Rathi S, Satsangi S, Roy A and MMPHCRF Investigators. Decentralized Care with All Generic Direct Anti-virals (DAAs) is Effective in the Management of Patients with Hepatitis C in a Public Health Care Setting: The Punjab Model. NEJM 2019 (Submitted).

    • Reporting the results of 48,088 chronic hepatitis C patients in the State of Punjab under MMPHCRF from 18 Jun 2016 to 31 Jul 2018.

  • Chug Y, Dhiman RK, Premkumar M, Prinja S, Bahuguna P, Grover GS. Cost-Effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India. Plus One (Submitted).

    • A cost-eefective analysis of three scnarios, i.e., I (Regimen till 31 July 2018) - use of SOF + daclatasvir (DCV) for non-cirrhotic patients and ledipasvir (LDV) or DCV with SOF ± ribavirin (RBV) according to the genotype for cirrhotic patients; II (Current Regiman at both State and National level)- use of SOF + DCV for non-cirrhotic patients and use of SOF+VEL for compensated cirrhotic patients (with RBV in decompensated cirrhosis patients) and III - use of SOF+VEL for both non-cirrhotic and compensated cirrhotic patients (with RBV in decompensated cirrhosis patients). Use of SOF+VEL for cirrhotic patients alone (scenario II) is a dominant intervention and should be recommended for free treatment under publicly funded program.

  • Dhiman RK, Grover GS, Premkumar M, Taneja S, Duseja A, Rathi S, Satsangi S. Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2018 Sep 11. doi: 10.1097/MPG.0000000000002139. [Epub ahead of print] PubMed PMID:30211847.

    • This study demonstrated that the decentralized algorithm-based public-health program could ensure high efficacy (SVR-12, 98.2%) and low-cost DAA based treatment of pediatric patients with chronic hepatitis C.

  • Arora A, Singh SP, Kumar A, Saraswat VA, Aggarwal R, Bangar M, Bhaumik P, Devarbhavi H, Dhiman RK, Dixit VK, Goel A, Goswami B, Kapoor D, Madan K, Narayan J, Nijhawan S, Pandey G, Rai RR, Sahu MK, Saraf N, Shalimar, Shenoy T, Thomas V, Wadhawan M; INASL Hepatitis B Taskforce. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. J Clin Exp Hepatol. 2018 Mar;8(1):58-80. doi: 10.1016/j.jceh.2017.12.001. Epub 2017 Dec 16. Review. PubMed PMID: 29743798; PubMed Central PMCID: PMC5938334.
  • Taneja S, Duseja A, De A, Mehta M, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Dhiman RK, Chawla Y. Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease. Dig Dis Sci. 2018 May;63(5):1334-1340. doi: 10.1007/s10620-018-4979-6. Epub 2018 Feb 26. PubMed PMID: 29484572.

    • Our experience with DAAs in Chronic Hepatitis C Patients with Severe Renal Impairment or End-Stage Renal Disease. This study demonstrated that it is effective..

  • Premkumar M, Grover GS, Dhiman RK. Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs? J Clin Exp Hepatol. 2017 Sep;7(3):253-261. doi: 10.1016/j.jceh.2017.08.003. Epub 2017 Sep 23. Review. PubMed PMID: 28970713; PubMed Central PMCID: PMC5620363.

    • Low-cost generics treatment in India (< 1 USD / day) is as effective as Branded drugs.

  • Sahu SK, Taneja S, Kalra N, Dhiman RK, Chawla YK, Duseja A, Singh V. Rupture of Hepatocellular Carcinoma: a Tale of 20 Cases from a Tertiary Care Center in Northern India. J Gastrointest Cancer. 2018 Feb 4. doi:10.1007/s12029-018-0063-x.
  • Makol A, Kanthaje S, Dhiman RK, Kalra N, Chawla YK, Chakraborti A. Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma. Exp Biol Med (Maywood). 2018 Feb;243(4):323-326.
  • Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla YK. Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment. Ann Hepatol. 2017;16:818-821.
  • Taneja S, Duseja A, De A, Kumar V, Ramachandran R, Sharma A, Dhiman RK, Gupta KL, Chawla Y. Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients. Nephrology (Carlton). 2017 Jul 13. doi: 10.1111/nep.13109.
  • Dhiman RK, Grover GS, Puri P. Hepatitis C in India. The Hepatitis B and C Public Policy Association's Newsletter 2017 (Europe).
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the Hepatitis C Disease Burden in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul;144(1):1-5.
  • Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital. J Clin Exp Hepatol. 2016 Dec;6(4):282-290.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016 Sep 14. doi:10.1111/jgh.13595.
  • Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol. 2016 Jun;6(2):119-45. doi: 10.1016/j.jceh.2016.07.001.
  • Singla B, Bhattacharyya R, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Response to potent anti-HBV agents in chronic hepatitis B and combined effect of HBV reverse transcriptase mutations. Gene. 2015: S0378-1119(15)00487-4.
  • Puri P, Anand AC, Saraswat VA, Acharya SK, Sarin SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoor D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India. J Clin Exp Hepatol. 2014;4:117-40.
  • Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, Singh SP, Amarapurkar D, Arora A, Chhabra M, Chetri K, Choudhuri G, Dixit VK, Duseja A, Jain AK, Kapoorz D, Kar P, Koshy A, Kumar A, Madan K, Misra SP, Prasad MV, Nagral A, Puri AS, Jeyamani R, Saigal S, Sarin SK, Shah S, Sharma PK, Sood A, Thareja S, Wadhawan M. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014;4:106-16.
  • Dhiman RK. Future of therapy for Hepatitis C in India: A Matter of Accessibility and Affordability? J Clin Exp Hepatol. 2014;4:85-6.
  • Kalra N, Kang M, Bhatia A, Duseja AK, Dhiman RK, Arya VK, Rajwanshi A, Chawla YK, Khandelwal N. Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience. Indian J Radiol Imaging. 2013;23:139-44.
  • Sharma BK, Srinivasan R, Kapil S, Singla B, Chawla YK, Chakraborti A, Saini N, Duseja A, Das A, Kalra N, Dhiman RK. Angiogenic and anti-angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma. Mol Biol Rep. 2013;40:5843-52.
  • Sharma BK, Srinivasan R, Kapil S, Singla B, Saini N, Chawla YK, Chakraborti A, Duseja A, Kalra N, Dhiman RK. Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma. Mol Cell Biochem. 2013;383:103-12.
  • Kanwar AJ, Vinay K, Heelan K, Walsh S, Shear NH, Dhiman RK. Use of rituximab in pemphigus patients with chronic viral hepatitis: Report of three cases. Indian J Dermatol Venereol Leprol. 2014;80:422-6.
  • Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients. Mol Biol Rep. 2014;41:4689-96.
  • Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients. J Med Virol. 2013;85:1155-62.
  • Kanwar AJ, Vinay K, Heelan K, Walsh S, Shear NH, Dhiman RK. Use of rituximab in pemphigus patients with chronic viral hepatitis: report of three cases. Indian J Dermatol Venereol Leprol. 2014 Sep-Oct;80(5):422-6.
  • Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients. Mol Biol Rep. 2014 Jul;41(7):4689-96.
  • Guleria A, Duseja A, Kalra N, Das A, Dhiman RK, Chawla Y, Bhansali A. Patients with non-alcoholic fatty liver disease (NAFLD) have an increased risk of atherosclerosis and cardiovascular disease. Trop Gastroenterol. 2013;34:74-82.
  • Singla B, Chakraborti A, Sharma BK, Kapil S, Chawla YK, Arora SK, Das A, Dhiman RK, Duseja A. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients. J Med Virol. 2013;85:1155-62.
  • Kumar A, Sharma A, Duseja A, Das A, Dhiman RK, Chawla YK, Kohli KK, Bhansali A. Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. J Clin Exp Hepatol. 2013;3:12-8.
  • Dhiman RK, Saraswat VA, Rajekar H, Reddy C, Chawla YK. A guide to the management of tuberculosis in patients with chronic liver disease. J Clin Exp Hepatol. 2012;2:260-70.
  • Rana D, Menachery J, Chawla Y, Duseja A, Dhiman RK, Arora S. HBV specific T-cell responses in hepatitis B. Trop Gastroenterol. 2011;32:273-8.
  • Vasishta R, Kakkar N, Duseja AK, Dhiman RK. Fatal hepatitis C in a renal transplant recipient on immunosuppression. J Clin Exp Hepatol. 2012;2:191-2.
  • Tohra SK, Taneja S, Ghosh S, Sharma BK, Duseja A, Dhiman RK, Das A, Chawla YK. Prediction of sustained virological response to combination therapy with pegylated interferon alfa and ribavirin in patients with genotype 3 chronic hepatitis C. Dig Dis Sci. 2011;56:2449-55.
  • Choudhary NS, Tomar M, Chawla YK, Bhadada SK, Khandelwal N, Dhiman RK, Duseja A, Bhansali A. Hepatic osteodystrophy is common in patients with noncholestatic liver disease. Dig Dis Sci. 2011;56:3323-7.
  • Duseja A, Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S. Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci. 2010;55:3188-92.
  • Sharma S, Sharma B, Singla B, Chawla YK, Chakraborti A, Saini N, Duseja A, Das A, Dhiman RK. Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. Dig Dis Sci. 2010;55:794-802.
  • Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. Immunology. 2009;128:e514-22.
  • Bali S, Kar SS, Kumar S, Ratho RK, Dhiman RK, Kumar R. Hepatitis E epidemic with bimodal peak in a town of north India. Indian J Public Health. 2008;52:189-93, 199.
  • Duseja A, Dhiman RK, Chawla YK. Chronic hepatitis C and diabetes mellitus--are they related? Trop Gastroenterol. 2008;29:121-2.
  • Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl. 2007;13:814-21.
  • Dhiman RK, Chawla Y. Acute viral hepatitis C should be treated. Indian J Gastroenterol. 2005;24:68-71
  • Wanchu A, Chawla Y, Dhiman RK, Sud A, Bambery P. Paucity of anti-hepatitis C virus antibodies in the serum of Indian patients with Sjogren's syndrome and inflammatory myositis. Indian J Pathol Microbiol. 2003;46:191-3.
  • Jain AK, Sukhija J, Saini JS, Chawla Y, Dhiman RK. Hepatitis C virus-associated keratitis. Eye (Lond). 2004;18:131-4.
  • Sharma RR, Dhiman RK, Chawla Y, Vasistha RK. Immunohistochemistry for core and surface antigens in chronic hepatitis. Trop Gastroenterol. 2002;23:16-9.
  • Sharma S, Sharma B, Singla B, Chawla YK, Chakraborti A, Saini N, Duseja A, Das A, Dhiman RK. Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. Dig Dis Sci. 2010;55:794-802.
  • Sharma A, Chakraborti A, Das A, Dhiman RK, Chawla Y. Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis. Immunology. 2009;128:e514-22.
  • Dhiman RK, Chawla Y. Acute viral hepatitis C should be treated. Indian Journal of Gastroenterology 2005;24:68-71 (Invited Expert Opinion)
  • Varma S, Dhiman RK, Srivastava D, Malhotra P, Chawla Y. Absence of hepatitis C virus infection among patients with lymphoproliferative disorders in northern India. Gastroenterology 2004;126:1498-9.
  • Satsangi S, Duseja A, Sachdeva M, Tomer S, Arora SK, Taneja S, Dhiman RK, Chawla YK. Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure. PLoS One. 2018 Jul 18;13(7):e0200644. doi: 10.1371/journal.pone.0200644. eCollection 2018. PubMed PMID: 30020985; PubMed Central PMCID: PMC6051623.
  • Rathi S, Fagan A, Wade JB, Chopra M, White MB, Ganapathy D, Acharya C, Dhiman RK, Bajaj JS. Patient Acceptance of Lactulose Varies Between Indian and American Cohorts: Implications for Comparing and Designing Global Hepatic Encephalopathy Trials. J Clin Exp Hepatol. 2018 Jun;8(2):109-115. doi:10.1016/j.jceh.2017.11.010. Epub 2017 Dec 2. PubMed PMID: 29892171; PubMed Central PMCID: PMC5992302.
  • Gupta T, Dhiman RK, Ahuja CK, Agrawal S, Chopra M, Kalra N, Duseja A, Taneja S, Khandelwal N, Chawla Y. Characterization of Cerebral Edema in Acute-on Chronic Liver Failure. J Clin Exp Hepatol. 2017;7:190-197.
  • Puri P, Saraswat VA, Dhiman RK, et al. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol. 2016;6:119-45.
  • Taneja S, Dhiman RK. Can Testing the Impact of Minimal Hepatic Encephalopathy on Driving Skills be Prolific to Translate Research to Real Life Clinical Medicine? J Clin Exp Hepatol. 2016;6:1-2.
  • Dhiman RK, Rana B, Agrawal S, Garg A, Chopra M, Thumburu KK, Khattri A, Malhotra S, Duseja A, Chawla YK. Efficacy of Probiotic in Patients with Advanced Liver Cirrhosis: A Double-Blind, Randomized, Placebo Controlled Trial. Gastroenterology 2014;147:1327-37
  • Dhiman RK, Agrawal S, Gupta T, Duseja A, Chawla Y. Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome. World J Gastroenterol. 2014; 28;20:14934-41.
  • Agrawal S, Duseja A, Gupta T, Dhiman RK, Chawla Y. Simple organ failure count versus CANONIC grading system for predicting mortality in acute-on-chronic liver failure. J Gastroenterol Hepatol. 2015;30:575-81.
  • Umapathy S, Dhiman RK, Grover S, Duseja A, Chawla YK. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Am J Gastroenterol. 2014;109:1011-9.
  • Thumburu KK, Dhiman RK, Vasishta RK, Chakraborti A, Butterworth RF, Beauchesne E, Desjardins P, Goyal S, Sharma N, Duseja A, Chawla Y. Expression of astrocytic genes coding for proteins implicated in neural excitation and brain edema is altered after acute liver failure. Neurochemistry International 2014;128:617-27.
  • Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis. 2013;14:484-90.
  • Samanta J, Dhiman RK, Khatri A, Thumburu KK, Grover S, Duseja A, Chawla Y. Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis. Metab Brain Dis. 2013;28:249-59
  • Dhiman RK. Gut microbiota and hepatic encephalopathy. Metab Brain Dis. 2013;28:321-6.
  • Thumburu KK, Taneja S, Vasishta RK, Dhiman RK. Neuropathology of acute liver failure. Neurochem Int. 2012;60:672-5.
  • Taneja S, Chawla Y, Dhiman RK. Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation. Hepatol Int. 2011.[Epub ahead of print]
  • Duseja A, Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S. Non-hepatic Insults Are Common Acute Precipitants in Patients with Acute on Chronic Liver Failure (ACLF). Dig Dis Sci. 2010;55:3188-92
  • Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, Chawla Y. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010;53:849-55
  • Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK; Indian National Association for Study of the Liver. Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver. J Gastroenterol Hepatol. 2010;25:1029-41
  • Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55:2381-90
  • Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16.
  • Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: time to recognise and treat. Trop Gastroenterol. 2008;29:6-12
  • Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Digestive Diseases and Sciences. 2008;53:2793-8
  • Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549-559
    Associated Editorial: Qadri AM, Ogunwale BO, Mullen KD. Can we ignore minimal hepatic encephalopathy any longer? Hepatology. 2007;45:547-8.
    Comments in: Hepatology. 2007;46:949-50; author reply 951,
    Hepatology. 2007;46:950; author reply 951.
  • Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla YK. Early indicators of prognosis in fulminant hepatic failure: An assessment of the model for end-stage liver disease (MELD) and King’s College hospital criteria. Liver Transplantation 2007;13:814-21

    Associated Editorial: O'Grady JG. Prognostication in acute liver failure: a tool or an anchor? Liver Transplantaion 2007;13:786-7

  • Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: should we start treating it? Gastroenterology 2004;127:1855-7
  • Duseja A, Dhiman RK, Saraswat V, Chawla Y. Natural history of subclinical hepatic encephalopathy, its impact and treatment on daily function. Indian Journal of Gastroenterology 2003;22:42-44
  • Venkatesh SK, Saha M, Dhiman RK, Gupta RK. Hepatic encephalopathy: Magnetic resonance imaging and spectroscopy. Indian Journal of Gastroenterology 2003;22:45-49.
  • Kharbanda PS, Saraswat VA, Dhiman RK. Minimal hepatic encephalopathy: Diagnosis by neuropsychological and neurophysiologic methods. Indian Journal of Gastroenterology 2003;22:37-41
  • Duseja A, Sachdev A, Dhiman RK, Y Chawla.Helicobactor pylori and hepatic encephalopathy. Indian Journal of Gastroenterology 2003;22:31-32
  • Das A, Dhiman RK, Saraswat VA, Naik SR. Prevelence and natural history of subclinical hepatic encephalopathy in cirrhosis. Journal of Gastroenterology and Hepatology 2001; 16:531-535
  • Dhiman RK, Chawla Y, Jain S. Spontaneous bacterial peritonitis and bacteremia in fulminant hepatic failure. American Journal of Gastroenterology 2000; 95:2126-2128
  • Dhiman RK, Sawhney IMS, Chawla Y., Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Digestive Diseases and Sciences 2000; 45:1549-1552
  • Dhiman RK, Makharia G, Jain S, Chawla YK. Ascites and spontaneous bacterial peritonitis in fulminant hepatic failure. American Journal of Gastroenterology 2000; 95: 233-238.
  • Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB.Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Digestive Diseases and Sciences 1998; 43: 1311-1316.

    Received “Shakuntala Amir Chand Award” by ICMR for the same in 1998.

  • Poddar U, Chawla Y, Dhiman RK, Vaiphei K, Vasishta RK, Dilawari JB. Spontaneous bacterial peritonitis in fulminant hepatic failure. Journal of Gastroenterology and Hepatology 1998; 13: 109-111
  • Sawhney IMS, Verma RK, Dhiman RK, Chopra JS, Sharma A, Chawla YK, Dilawari JB. Visual and auditory evoked responses in acute severe hepatitis. Journal of Gastroenterology and Hepatology 1997; 12: 554 559
  • Dhiman RK, Saraswat VA, Verma M, Naik SR.Figure connection test: A modified number connection test for the objective assessment of mental state in illiterates. Journal of Gastroenterology & Hepatology 1995; 10: 14 23
  • Gupta RK, Saraswat VA, Dhiman RK, Poptani H, Gujral RB, Naik SR. Serial proton MR spectroscopy and imaging changes in patients recovering from fulminant hepatic failure. American Journal of Gasroenterology 1993; 88: 670 74
  • Dhiman RK, Chawla Y. Scientific advances in hepatic encephalopathy. Indian Journal of Gastroenterology 2003;22:1-2
  • Saraswat VA, Rai P, Kumar T, Mohindra S, Dhiman RK. Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy. J Clin Exp Hepatol. 2014;4:67-76.
  • Dhiman RK, Saraswat VA, Valla DC, Chawla Y, Behera A, Varma V, Agarwal S, Duseja A, Puri P, Kalra N, Rameshbabu CS, Bhatia V, Sharma M, Kumar M, Gupta S, Taneja S, Kaman L, Zargar SA, Nundy S, Singh SP, Acharya SK, Dilawari JB. Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver. J Clin Exp Hepatol. 2014;4:2-S14.
  • Aggarwal N, Negi N, Aggarwal A, Bodh V, Dhiman RK. Pregnancy with portal hypertension. J Clin Exp Hepatol. 2014;4:163-71.
  • Kumar A, Ahuja CK, Vyas S, Kalra N, Khandelwal N, Chawla Y, Dhiman RK. Hepatic arteriovenous fistulae: role of interventional radiology. Dig Dis Sci. 2012;57:2703-12.
  • Anand MS, Bahl A, Bodh V, Dhiman RK. Recent onset dyspnea in a patient with cirrhosis of liver. J Clin Exp Hepatol. 2011;1:212.
  • Rajekar H, Vasishta RK, Chawla YK, Dhiman RK. Noncirrhotic portal hypertension. J Clin Exp Hepatol. 2011;1:94-108.
  • Varma S, Kumar S, Garg A, Malhotra P, Das A, Sharma A, Chawla YK, Dhiman RK. Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India. J Clin Exp Hepatol. 2011;1:68-72.
  • Dhiman RK. Spectrum of idiopathic noncirrhotic portal hypertension. J Clin Exp Hepatol. 2011;1:55-6.
  • Taneja S, Dhiman RK. Non-cirrhotic Portal Fibrosis and Gamma-Gandy Bodies. J Clin Exp Hepatol. 2011;1:48.
  • Dhiman RK, Chowdhry N, Chawla YK. Has the time come for cyanoacrylate injection to become the standard-of-care for gastric varices? Trop Gastroenterol. 2010;31:141-4.
  • Sharma M, Babu CS, Dhiman RK, Chawla Y. Induced hypotension in the management of acute hemobilia during therapeutic ERCP in a patient with portal biliopathy (with videos). Gastrointest Endosc. 2010;72:1317-9.
  • Sodhi KS, Saxena AK, Khandelwal N, Dhiman RK. Giant paraumblical veins in Cruveilhier-Baumgarten syndrome. Gastrointest Endosc. 2010;72:435-6; discussion 436.
  • Taneja S, Kalra N, Duseja A, Dhiman RK. Noncirrhotic portal fibrosis and abdominal varices. Liver Int. 2010;30:715-7.
  • Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30:881-94.
  • Sarin SK, Kumar A, Angus PW, Baijal SS, Chawla YK, Dhiman RK, Janaka de Silva H, Hamid S, Hirota S, Hou MC, Jafri W, Khan M, Lesmana LA, Lui HF, Malhotra V, Maruyama H, Mazumder DG, Omata M, Poddar U, Puri AS, Sharma P, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Shah HA, Shiha G, Sollano J; APASL Working Party on Portal Hypertension. Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver. Hepatol Int. 2008;2:429-39.
  • Chawla Y, Dhiman RK. Intrahepatic portal venopathy and related disorders of the liver. Semin Liver Dis. 2008;28:270-81.
  • Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci. 2008;53:2793-8.
  • Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, Lesmana LA, Guha Mazumder D, Omata M, Qureshi H, Raza RM, Sahni P, Sakhuja P, Salih M, Santra A, Sharma BC, Sharma P, Shiha G, Sollano J; Members of the APASL Working Party on Portal Hypertension. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int. 2007;1:398-413.
  • Dhiman RK, Behera A, Chawla YK, Dilawari JB, Suri S. Portal hypertensive biliopathy. Gut. 2007;56:1001-8.
  • Chawla Y, Dhiman RK. Portal biliopathy: emerging management problems. Trop Gastroenterol. 2003;24:165-6.
  • Dhiman RK, Chawla YK. A new technique of combined endoscopic sclerotherapy and ligation for variceal bleeding. World J Gastroenterol. 2003;9:1090-3.
  • Dhiman RK, Chawla Y, Taneja S, Biswas R, Sharma TR, Dilawari JB. Endoscopic sclerotherapy of gastric variceal bleeding with N-butyl-2-cyanoacrylate. J Clin Gastroenterol. 2002;35:222-7.
  • Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, Puri P, Mitra SK, Suri S. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 2002;17:6-16.
  • Makharia G, Dhiman RK, Chawla YK, Vasistha RK. Non-cirrhotic portal fibrosis in a patient with rheumatoid arthritis. Indian J Gastroenterol. 2001;20:197-8.
  • Satapathy SK, Narayan S, Varma N, Dhiman RK, Varma S, Chawla Y. Hyposplenism in alcoholic cirrhosis, facts or artifacts? A comparative analysis with non-alcoholic cirrhosis and extrahepatic portal venous obstruction. J Gastroenterol Hepatol. 2001;16:1038-43.
  • Chawla Y, Sreedharan A, Dhiman RK, Jain S, Suri S. Portal hemodynamics in fulminant hepatic failure as assessed by duplex Doppler ultrasonography. Dig Dis Sci. 2001;46:504-8.
  • Aggarwal N, Sawhney H, Vasishta K, Dhiman RK, Chawla Y. Non-cirrhotic portal hypertension in pregnancy. Int J Gynaecol Obstet. 2001;72:1-7
  • Gupta D, Chawla YK, Dhiman RK, Suri S, Dilawari JB. Clinical significance of patent paraumbilical vein in patients with liver cirrhosis. Dig Dis Sci. 2000;45:1861-4.
  • Dhiman RK, Chawla YK. Is the technique of endoscopic sclerotherapy and ligation (ESL) optimum? Gastrointest Endosc. 2000;51:639-40.
  • Aggarwal N, Sawnhey H, Suril V, Vasishta K, Jha M, Dhiman RK. Pregnancy and cirrhosis of the liver. Aust N Z J Obstet Gynaecol. 1999;39:503-6.
  • Dhiman RK, Biswas R, Aggarwal N, Sawhney H, Chawla Y. Management of variceal bleeding in pregnancy with endoscopic variceal ligation and N-butyl-2-cyanoacrylate: report of three cases. Gastrointest Endosc. 2000;51:91-3.
  • Dhiman RK, Puri P, Chawla Y, Minz M, Bapuraj JR, Gupta S, Nagi B, Suri S. Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic? Gastrointest Endosc. 1999;50:646-52.
  • Dhiman RK, Saraswat VA, Choudhuri G, Sharma BC, Pandey R, Naik SR. Endosonographic, endoscopic, and histologic evaluation of alterations in the rectal venous system in patients with portal hypertension. Gastrointest Endosc. 1999 Feb;49:218-27.
  • Ghoshal UC, Saraswat VA, Aggarwal R, Misra A, Dhiman RK, Naik SR. Oesophageal motility and gastro-oesophageal reflux: effect of variceal eradication by endoscopic sclerotherapy. J Gastroenterol Hepatol. 1998;13:1033-8.
  • Dhiman RK, Chawla YK. Images in hepatology. Large splenorenal shunt in portal venous obstruction. J Hepatol. 1997;27:216.
  • Chawla YK, Dilawari JB, Dhiman RK, Goenka MK, Bhasin DK, Kochhar R, Singh K, Kaur U. Sclerotherapy in noncirrhotic portal fibrosis. Dig Dis Sci. 1997;42:1449-53.
  • Choudhuri G, Dhiman RK, Agarwal DK. Endosonographic evaluation of the venous anatomy around the gastro-esophageal junction in patients with portal hypertension. Hepatogastroenterology. 1996;43:1250-5.
  • Dhiman RK, Choudhuri G, Saraswat VA, Agarwal DK, Naik SR. Role of paraoesophageal collaterals and perforating veins on outcome of endoscopic sclerotherapy for oesophageal varices: an endosonographic study. Gut. 1996;38:759-64.

    • Received “Dr DV Datta Memorial Oration Award” by ICMR for the same in 1998

  • Sharma BC, Saraswat VA, Dhiman RK, Ghoshal UC, Puri AS, Sikora SS. Unusual tumors causing extrahepatic portal venous obstruction. HPB Surg. 1996;9:165-7.
  • Dhiman RK, Choudhuri G, Saraswat VA, Mukhopadhyay DK, Khan EM, Pandey R, Naik SR. Endoscopic ultrasonographic evaluation of the rectum in cirrhotic portal hypertension. Gastrointest Endosc. 1993;39:635-40.
  • Dhiman RK, Saraswat VA, Radhakrishnan S, Parashar A, Agarwal DK, Naik SR. Multiple venous thromboses and membranous obstruction of inferior vena cava in association with hereditary protein C deficiency: a case report. J Gastroenterol Hepatol. 1992;7:434-8.
  • Dhiman RK, Chawla YK. Hormone replacement therapy and gallstone disease: a real association. Digestion. 2008;77:1-3. (Invited Editorial) Editorial on the EPIC-Norfolk Cohort study.
  • Dhiman RK, Chawla Y. Is there a link between oestrogen therapy and gallbladder disease? Expert Opinion in Drug Safety 2006;5:117-29. (Invited Review)
  • Dhiman RK, Sarkar PK, Sharma A, Vasishta K, Kohli KK, Gupta S, Suri S, Chawla Y. Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy. Digestive Diseases and Sciences 2004;49:1335-41.
  • Dhiman RK, Arke L, Bhansali A, Gupta S, Chawla Y. Cisapride improves gallbladder emptying in patients with diabetes mellitus. Journal of Gastroenterology and Hepatology. 2001; 16:1044-50.
  • Dhiman RK, Reddi R, Sharma A, Singh R, Kohli KK, Chawla Y. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones. Journal of Gastroenterology and Hepatology 2001; 16:816-20.
  • Dhiman RK, Makharia G, Gupta S, Chawla Y, Suri S. T Tube assistance for endoscopic sphincterotomy: A variance of combined percutaneous and endoscopic approach. Indian Journal of Gastroenterology 1999; 18: 29-30.
  • Sharma BC, Agarwal DK, Dhiman RK, Baijal SS, Choudhuri G, Saraswat VA. Bile lithogenicity and gallbladder motility in patients with microlithiasis: Effect of bile acid therapy. Gastroenterology 1998; 115: 124-128.
  • Agarwal DK, Sharma BC, Dhiman RK, Saraswat VA, Baijal SS, Choudhuri G. The effect of endoscopic sphincterotomy on gallbladder motility. Digestive Diseases and Sciences 1997: 42: 1495-1500.
  • Nagral A, Sarma MS, Matthai J, Kukkle PL, Devarbhavi H, Sinha S, Alam S, Bavdekar A, Dhiman RK, et al. Wilson’s Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol 2019 Feb;9:1-25
  • Taneja S, Borkakoty A, Rathi S, Kumar V, Duseja A, Dhiman RK, Gupta KL, Chawla Y. Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease. Dig Dis Sci. 2017;62:3186-3192.
  • Agrawal S, Duseja A, Aggarwal A, Das A, Mehta M, Dhiman RK, Chawla Y. Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center. Hepatol Int. 2015;9:283-91.
  • Duseja A, Singh SP, Saraswat VA, Acharya SK, Chawla YK, Chowdhury S, Dhiman RK, Jayakumar RV, Madan K, Misra SP, Mishra H, Modi SK, Muruganathan A, Saboo B, Sahay R, Upadhyay R. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. J Clin Exp Hepatol. 2015;5:51-68.
  • Kumar A, Sharma A, Duseja A, Das A, Dhiman RK, Chawla YK, Kohli KK, Bhansali A. Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. J Clin Exp Hepatol. 2013;3:12-8.
  • Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2012;11:478-86.
  • Dhiman RK. Non-alcoholic Fatty Liver Disease Progression: All Depends on the Inflammasome Deficiency Driven Dysbiosis. J Clin Exp Hepatol. 2012;2:101-2.
  • Duseja A, Dhiman RK, Chawla Y, Thumburu KK, Kumar A, Das A, Bhadada S, Bhansali A. Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. Dig Dis Sci. 2009;54:1778-82.
  • Kalra N, Duseja A, Das A, Dhiman RK, Virmani V, Chawla Y, Singh P, Khandelwal N. Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009;8:21-5.
  • Duseja A, Das A, Dhiman RK, Chawla YK, Thumburu KT, Bhadada S, Bhansali A. Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol. 2007;6:222-6.
  • Duseja A, Thumburu KK, Das A, Dhiman RK, Chawla YK, Bhadada S, Bhansali A. Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. Indian J Gastroenterol. 2007;26:170-3.
  • Dhillon BK, Das R, Garewal G, Chawla Y, Dhiman RK, Das A, Duseja A, Chandak GR. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol. 2007;13:2956-9.
  • Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, Kalra N. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci. 2007;52:2368-74.
  • Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Tan SS, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab MA, Ghazinyan H, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, Lesmana LA, Lesmana CR, Sollano JD, Carpio G, Sahu MK, Kumar G, Sarin SK; APASL ACLF (AARC) working party. Flare of Autoimmune Hepatitis causing acute on chronic liver failure (ACLF): diagnosis and response to corticosteroid therapy. Hepatology. 2018 Aug 16. doi: 10.1002/hep.30205. [Epub ahead of print] PubMed PMID: 30113706.
  • Moudgil S, Kalra N, Prabhakar N, Dhiman RK, Behera A, Chawla YK, Khandelwal N. Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma. J Clin Exp Hepatol. 2017;7:222-229.
  • Dhiman RK. The Fifth Year of JCEH: The Year of Recognition. J Clin Exp Hepatol. 2015;5:1.
  • Kumar R, Chawla YK, Garg SK, Dixit RK, Satapathy SK, Dhiman RK, Bhargava VK. Pharmacokinetics of omeprazole in patients with liver cirrhosis and extrahepatic portal venous obstruction. Methods Find Exp Clin Pharmacol 2003;25:625-30.
  • Sharma S, Sharma B, Singla B, Chawla YK, Chakraborti A, Saini N, Duseja A, Das A, Dhiman RK. Clinical significance of genotypes and precore/basal core promoter mutations in HBV related chronic liver disease patients in North India. Dig Dis Sci. 2010;55:794-802. .
  • Dhillon BK, Das R, Garewal G, Chawla Y, Dhiman RK, Das A, Duseja A, Chandak GR. Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India. World J Gastroenterol. 2007;13:2956-9.
  • Lamba JK, Dhiman RK, Singh R, Kohli KK. Correlation between omeprazole hydroxylase and CYP2C19 genotype in North Indians. JK Lamba. Europian Journal of Clinical Pharmacology 2001;57:649-52.
  • Lamba JK, Dhiman RK, Kohli KK. CYP2C19 mutations in North Indians. Clinical Pharmacology and Therapeutics 2000; 68:328-335.
  • Lamba JK, Dhiman RK, Kohli KK. Genetic polymorphism of the hepatic cytochrome P450 2C19 in North Indian subjects. Clinical Pharmacology and Therapeutics 1998: 63: 422-427.
  • Guest Editor:
    • Hepatic Encephalopathy. J Clin Exp Hepatol 2015. Supplement 1.
    • Hepatic Encephalopathy. Proceedings of Current Perspective in Liver Disease 2000. Guest Editors: RK Dhiman, Y Chawla. Indian Journal of Gastroenterology 2003; 22, Supplement 2: S1-S80.
  • Monographs
    • Hepatic Encephalopathy. Proceedings of Current Perspective in Liver Disease 2000. Guest Editors: Y Chawla, RK Dhiman. Indian Journal of Gastroenterology 2003; 22, Supplement 2. This monograph was published as proceedings of Single Theme Conference on Current Perspective in Liver Disease 2000 (CPLD 2000). It provides state of art articles on all aspects of hepatic encephalopathy.
    • Naik SR, Dhiman RK. Peptic ulcer. Quarterly Medical Review 1993;44. Raptakos, Brett & Co. Ltd. Mumbai
  • Chapters
    • Dhiman RK and Rathi S. Hepatic encephalopathy: classification,diagnosis, and treatment. CHAPTER 44: Wiley-Blackwell / Evidence-Based Gastroenterology and Hepatology, 4e 2019.
    • Dhiman RK, Premkumar M. Chronic viral hepatitis. In: API Text Book of Medicine; 11th Ed.; 2019.
    • Dhiman RK. Chronic viral hepatitis. In: API Text Book of Medicine; 10th Ed. YP Munjal; 2015.
    • Dhiman RK. Investigations in hepatic disorders. In: API Text Book of Medicine; 9th Ed. YP Munjal; 2011
    • Dhiman RK, Chawla YK: Noncirrhotic portal fibrosis. In: Tropical Hepatogastroenterology. Elsevier, Reed Elsevier India Private Limited. B.N. Tandon (ed.) 2008; 388-403
    • Dhiman RK. Investigations in hepatic disorders. In: API Text Book of Medicine; 8th Ed. SC Shah; 2008
    • Dhiman RK. What are the indications of liver transplantation in acute liver failure? In: 100 clinical questions in Gastroenterology. Ajay Kumar, Manav Wadhavan (eds.) 2007; 26-28.
    • Dhiman RK, Solanki K. Management of Hepatic Encephalopathy: Seen and Unseen. In: Medicine Update Vol 17; Ed YP Munjal.2007; pp 259-271.
    • Dhiman RK, Chawla Y, Vasistha RK. Noncirrhotic portal hypertension (Idiopathic portal hypertension). In: Portal Hypertension: Pathogenesis & Management; Ed Ahmed Helmy, 2005; pp 339-364.
    • Dhiman RK, Chawla Y. Portal biliopathy. In: Portal Hypertension: Pathogenesis & Management; Ed Ahmed Helmy, 2005; pp 167-178.
    • Dhiman RK, Duseja A. Nonalcoholic Fatty Liver Disease. In: Medicine Update Vol 15; Ed S B Gupta.2005; pp 469-475.
    • Dilawari JB,Dhiman RK. Ed. N Kumar, SK Acharaya. Imaging of pancreas in tropical pancreatitis. Roussal Scientific Institute, India.1994, Pp 49 64.
    • Saraswat VA, Dhiman RK. Current concepts in gastroesophageal reflux disease. In SGPI Gastroenterology Clinics 1999. Workshop Mannual, SGPGIMS, Lucknow pp. 7-18.
    • Dhiman RK, Naik SR. Acute hepatic encephalopathy: Newer therapeutic approach.In: Medicine Update Vol 2; Ed S Mukherjee.1992; pp 163 70.
    • Dhiman RK, Saraswat VA. Overt and subclinical hepatic encephalopathy: An overview of diagnosis and management. In Medicine Update 1991; Ed Govil M; 272 279.
    • Dhiman RK, Saraswat VA. Ambulatory esophageal pH monitoring: technique, interpretations and clinical implications. SGPGIMS, Lucknow. Pp 37-50.